Clinical trial
A Double-Blind, Placebo-Controlled, Randomized Three-Way Crossover Study to Investigate The Effect of Nicotine on Arousal, Standard Cognitive Tasks And Social Cognition in Patients With Schizophrenia (Smoking and Non-Smoking)
NCT01186471 is registered in ClinicalTrials.gov with Janssen Pharmaceutica N.V., Belgium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled, Randomized Three-Way Crossover Study to Investigate The Effect of Nicotine on Arousal, Standard Cognitive Tasks And Social Cognition in Patients With Schizophrenia (Smoking and Non-Smoking)
- Lead sponsor
- Janssen Pharmaceutica N.V., Belgium
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- March 31, 2011
- Enrollment
- 32 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.